Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6980505rdf:typepubmed:Citationlld:pubmed
pubmed-article:6980505lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6980505lifeskim:mentionsumls-concept:C0020966lld:lifeskim
pubmed-article:6980505lifeskim:mentionsumls-concept:C0205370lld:lifeskim
pubmed-article:6980505lifeskim:mentionsumls-concept:C0036319lld:lifeskim
pubmed-article:6980505lifeskim:mentionsumls-concept:C0022558lld:lifeskim
pubmed-article:6980505pubmed:issue2lld:pubmed
pubmed-article:6980505pubmed:dateCreated1982-9-10lld:pubmed
pubmed-article:6980505pubmed:abstractTextParameters of in vitro cell-mediated immunity (CMI) have been measured in the local Kenyan population infected with Schistosoma mansoni. Lymphocyte responses to the non-specific T cell mitogens Concanavalin A (Con A) and Phytohaemagglutinin (PHA) were reduced in about 60% of schistosomiasis patients. Lymphocytes from control uninfected, and S. mansoni-infected donors formed equal numbers of spontaneous rosettes with sheep red blood cells, indicating that there was no over-all reduction in the percentage numbers of T cells in the schistosomiasis patients.lld:pubmed
pubmed-article:6980505pubmed:languageenglld:pubmed
pubmed-article:6980505pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6980505pubmed:citationSubsetIMlld:pubmed
pubmed-article:6980505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6980505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6980505pubmed:statusMEDLINElld:pubmed
pubmed-article:6980505pubmed:issn0035-9203lld:pubmed
pubmed-article:6980505pubmed:authorpubmed-author:ReesPPlld:pubmed
pubmed-article:6980505pubmed:authorpubmed-author:SturrockR FRFlld:pubmed
pubmed-article:6980505pubmed:authorpubmed-author:CottrellB JBJlld:pubmed
pubmed-article:6980505pubmed:authorpubmed-author:SeitzHHlld:pubmed
pubmed-article:6980505pubmed:authorpubmed-author:HumberDDlld:pubmed
pubmed-article:6980505pubmed:issnTypePrintlld:pubmed
pubmed-article:6980505pubmed:volume76lld:pubmed
pubmed-article:6980505pubmed:ownerNLMlld:pubmed
pubmed-article:6980505pubmed:authorsCompleteYlld:pubmed
pubmed-article:6980505pubmed:pagination234-7lld:pubmed
pubmed-article:6980505pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:meshHeadingpubmed-meshheading:6980505-...lld:pubmed
pubmed-article:6980505pubmed:year1982lld:pubmed
pubmed-article:6980505pubmed:articleTitleNon-specific cell mediated immunity in patients infected with Schistosoma mansoni in Kenya.lld:pubmed
pubmed-article:6980505pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6980505pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed